• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TERT 启动子突变在基底细胞癌和鳞状细胞癌中很常见。

Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.

机构信息

1] Department of Dermatology, University of Rochester School of Medicine, Rochester, NY, USA [2] Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine, Rochester, NY, USA.

Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine, Rochester, NY, USA.

出版信息

Mod Pathol. 2014 Apr;27(4):516-23. doi: 10.1038/modpathol.2013.167. Epub 2013 Sep 13.

DOI:10.1038/modpathol.2013.167
PMID:24030752
Abstract

Telomerase is frequently expressed in cancer and contributes to carcinogenesis. Two recent publications report the identification of a set of recurrent mutations in melanoma in the promoter of the telomerase reverse transcriptase gene (TERT) that appears to be the result of mutagenesis from ultraviolet (UV) radiation. Both groups reported that the mutations increase the transcription of TERT. This prompted our search for similar mutations in two other UV-related skin cancers, basal cell carcinoma, and squamous cell carcinoma. We found that the activating TERT promoter mutations reported in melanoma are also frequent in squamous cell carcinoma (50%) and basal cell carcinoma, the latter including both sporadic tumors (78%) and tumors from patients with nevoid basal cell carcinoma syndrome (68%). These mutations were found in only 1 of 11 Bowen's disease (squamous cell carcinoma in situ) specimens, and in none of 15 non-malignant skin specimens and 57 blood specimens. The mutations were frequently homozygous or hemizygous, with little or no normal signal at the mutated positions. These data suggest that TERT promoter mutations are the most frequent putative oncogenic mutations in cutaneous cancer.

摘要

端粒酶在癌症中经常表达,有助于癌症的发生。最近的两项研究报告了在端粒酶逆转录酶基因(TERT)启动子中发现了一组黑色素瘤的复发性突变,这些突变似乎是紫外线(UV)辐射引起的突变的结果。这两个研究小组都报告称,这些突变增加了 TERT 的转录。这促使我们在另外两种与紫外线有关的皮肤癌——基底细胞癌和鳞状细胞癌中寻找类似的突变。我们发现,黑色素瘤中报道的激活 TERT 启动子突变在鳞状细胞癌(50%)和基底细胞癌中也很常见,后者包括散发性肿瘤(78%)和神经嵴基底细胞痣综合征患者的肿瘤(68%)。这些突变仅在 11 个 Bowen 病(原位鳞状细胞癌)标本中的 1 个中发现,在 15 个非恶性皮肤标本和 57 个血液标本中均未发现。这些突变通常是纯合子或半合子的,在突变部位几乎没有或没有正常信号。这些数据表明,TERT 启动子突变是皮肤癌中最常见的潜在致癌突变。

相似文献

1
Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.TERT 启动子突变在基底细胞癌和鳞状细胞癌中很常见。
Mod Pathol. 2014 Apr;27(4):516-23. doi: 10.1038/modpathol.2013.167. Epub 2013 Sep 13.
2
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.TERT 启动子突变在皮肤基底细胞癌和鳞状细胞癌中很常见。
PLoS One. 2013 Nov 18;8(11):e80354. doi: 10.1371/journal.pone.0080354. eCollection 2013.
3
Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.端粒和端粒酶在皮肤鳞状细胞癌中的作用。
Int J Mol Sci. 2019 Mar 16;20(6):1333. doi: 10.3390/ijms20061333.
4
[Merkel cell polyomavirus in the pathogenesis of non-melanoma skin cancer].[默克尔细胞多瘤病毒在非黑色素瘤皮肤癌发病机制中的作用]
Pathologe. 2009 Dec;30 Suppl 2:217-20. doi: 10.1007/s00292-009-1222-4.
5
Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin.皮肤鳞状细胞癌患者中CDKN2A基因的突变分析。
Br J Dermatol. 2003 Apr;148(4):638-48. doi: 10.1046/j.1365-2133.2003.05230.x.
6
Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.台湾乌脚病流行地区砷相关皮肤癌中p53基因的突变谱
Br J Cancer. 1999 Jun;80(7):1080-6. doi: 10.1038/sj.bjc.6690467.
7
TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis.眼周癌中的端粒酶逆转录酶(TERT)启动子突变:紫外线在发病机制中的影响
Br J Ophthalmol. 2016 Feb;100(2):274-7. doi: 10.1136/bjophthalmol-2015-307503. Epub 2015 Oct 15.
8
Cytogenetics of melanoma and nonmelanoma skin cancer.黑色素瘤和非黑色素瘤皮肤癌的细胞遗传学。
Adv Exp Med Biol. 2014;810:160-81. doi: 10.1007/978-1-4939-0437-2_9.
9
Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.免疫组织化学可视化激活的 Hedgehog 信号通路在皮肤上皮肿瘤中的特征。
J Dermatol. 2018 Oct;45(10):1181-1186. doi: 10.1111/1346-8138.14543. Epub 2018 Jul 23.
10
TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation.皮肤癌中的端粒酶逆转录酶(TERT)启动子突变:阳光照射和X射线辐射的影响
J Invest Dermatol. 2014 Aug;134(8):2251-2257. doi: 10.1038/jid.2014.163. Epub 2014 Apr 1.

引用本文的文献

1
Ethnic-Specific and UV-Independent Mutational Signatures of Basal Cell Carcinoma in Koreans.韩国人基底细胞癌的种族特异性和紫外线非依赖性突变特征
Int J Mol Sci. 2025 Jul 19;26(14):6941. doi: 10.3390/ijms26146941.
2
High Prevalence of and Mutations in Brazilian HCC Tissues: Insights into Early Detection and Risk Stratification.巴西肝癌组织中 和 突变的高流行率:对早期检测和风险分层的见解
Int J Mol Sci. 2025 Jul 6;26(13):6503. doi: 10.3390/ijms26136503.
3
Molecular and cellular dynamics of squamous cell carcinomas across tissues.
跨组织鳞状细胞癌的分子与细胞动力学
Genes Dev. 2025 Jan 7;39(1-2):18-35. doi: 10.1101/gad.351990.124.
4
The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review.皮肤鳞状细胞癌的突变和微环境格局:综述
Cancers (Basel). 2024 Aug 21;16(16):2904. doi: 10.3390/cancers16162904.
5
Biomarkers in Cutaneous Keratinocyte Carcinomas.皮肤角质形成细胞癌中的生物标志物
Dermatol Ther (Heidelb). 2024 Aug;14(8):2039-2058. doi: 10.1007/s13555-024-01233-w. Epub 2024 Jul 20.
6
Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase () gene expression status.与端粒酶逆转录酶()基因表达状态相关的人类转录模式的泛癌实验特征。 需注意,原文中“telomerase reverse transcriptase ()”括号内内容缺失,可能会影响对完整准确意思的理解。
Front Genet. 2024 May 27;15:1401100. doi: 10.3389/fgene.2024.1401100. eCollection 2024.
7
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer.解析端粒酶逆转录酶在头颈癌中的功能
Biomedicines. 2023 Feb 24;11(3):691. doi: 10.3390/biomedicines11030691.
8
Comparison of the Basal Cell Carcinoma (BCC) Tumour Microenvironment to Other Solid Malignancies.基底细胞癌(BCC)肿瘤微环境与其他实体恶性肿瘤的比较。
Cancers (Basel). 2023 Jan 2;15(1):305. doi: 10.3390/cancers15010305.
9
Immunotherapy for the Treatment of Squamous Cell Carcinoma: Potential Benefits and Challenges.免疫疗法治疗鳞状细胞癌:潜在的益处和挑战。
Int J Mol Sci. 2022 Aug 1;23(15):8530. doi: 10.3390/ijms23158530.
10
Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma.结膜鳞状细胞癌中端粒酶逆转录酶的免疫组织化学和突变状态。
Indian J Ophthalmol. 2022 Mar;70(3):971-975. doi: 10.4103/ijo.IJO_1342_21.